Cytotoxic drug treatment of lupus nephritis
Donadio, J.V.; Holley, K.E.; Ilstrup, D.M.
American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation 2(1 Suppl 1: 178-181
1982
ISSN/ISBN: 0272-6386 PMID: 7102666 Document Number: 17106
Patients with lupus glomerulonephritis improved after various combinations of azathioprine or cyclophosphamide and prednisone treatment in uncontrolled studies reported in the early 1970s. Later prospective clinical trials tested the effectiveness of these cytotoxic immunosuppressants. No important differences were found in clinical effects, serologic tests of lupus activity, renal function, and proteinuria when groups of patients treated with prednisone were compared with those treated with combined azathioprine prednisone or cyclophosphamide prednisone. There has been a two-fold increase in the 5-yr cumulative survival of patients with diffuse proliferative lupus nephritis in studies appearing after 1970 versus those published before 1970. However, the improved survival cannot be attributed to azathioprine or cyclophosphamide treatment.
Document emailed within 1 workday
